SHUKLA SANJAY (President and CEO) purchased 120.5% of their position (10K shares) of ATYR PHARMA INC on the open market
Open‑market purchase worth $40.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2021ACC: 0001209191-21-034292
Officer· President and CEO
Since Feb 2019
+10K
Net shares
Net buyer
$40.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$4.01
Trade value
$40.10K
% of position
120.5%
5/18/2021
8.30K→18.30K
Total
Net shares
+10K
Net value
$40.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2021 | P · Purchase | +10K | $4.01 | $40.10K | 120.5% | 8.30K | 18.30K |
| Total | +10K | $40.10K | ||||||
Derivative Transactions0
No derivative transactions reported